Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: A real-world analysis Research Letter
| Authors: | Epperla, N.; Zhao, Q.; Moyo, T.; Watkins, M. P.; Tavakkoli, M.; Bello, C.; Torka, P.; Reddy, N.; Thomas, C.; Annunzio, K.; Christian, B.; Barta, S. K.; Shouse, G.; Olszewski, A. J.; Bartlett, N. L. |
| Title: | Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: A real-world analysis |
| Keywords: | adult; clinical article; treatment response; aged; clinical feature; cancer recurrence; cancer growth; united states; cancer staging; outcome assessment; follow up; cancer diagnosis; letter; demography; progression free survival; cohort analysis; retrospective study; cancer therapy; prediction; risk factor; cancer mortality; age; risk assessment; patient care; dementia; marginal zone lymphoma; treatment withdrawal; bone marrow examination; clinical examination; primary health care; case study; descriptive research; protocol compliance; ibrutinib; human; male; female |
| Journal Title: | Blood Advances |
| Volume: | 8 |
| Issue: | 3 |
| ISSN: | 2473-9529 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-02-13 |
| Start Page: | 549 |
| End Page: | 552 |
| Language: | English |
| DOI: | 10.1182/bloodadvances.2023011698 |
| PUBMED: | 38091577 |
| PROVIDER: | scopus |
| PMCID: | PMC10835265 |
| DOI/URL: | |
| Notes: | Letter -- Source: Scopus |
